EE02979B1 - Formoterool ja tema ühendid ning nende valmistamise meetod - Google Patents

Formoterool ja tema ühendid ning nende valmistamise meetod

Info

Publication number
EE02979B1
EE02979B1 EE9400425A EE9400425A EE02979B1 EE 02979 B1 EE02979 B1 EE 02979B1 EE 9400425 A EE9400425 A EE 9400425A EE 9400425 A EE9400425 A EE 9400425A EE 02979 B1 EE02979 B1 EE 02979B1
Authority
EE
Estonia
Prior art keywords
formoterol
compounds
preparation
directed
present
Prior art date
Application number
EE9400425A
Other languages
English (en)
Estonian (et)
Inventor
Katarina M�nsson Lena
Trofast Jan
Jakupovic Edib
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE02979B1 publication Critical patent/EE02979B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
EE9400425A 1990-09-26 1994-11-23 Formoterool ja tema ühendid ning nende valmistamise meetod EE02979B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003057A SE9003057D0 (sv) 1990-09-26 1990-09-26 New process

Publications (1)

Publication Number Publication Date
EE02979B1 true EE02979B1 (et) 1997-04-15

Family

ID=20380456

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400425A EE02979B1 (et) 1990-09-26 1994-11-23 Formoterool ja tema ühendid ning nende valmistamise meetod

Country Status (28)

Country Link
EP (1) EP0550612B1 (is)
JP (1) JP2801401B2 (is)
KR (1) KR0179639B1 (is)
AT (1) ATE134990T1 (is)
AU (1) AU652386B2 (is)
BG (1) BG61605B1 (is)
CA (1) CA2091343C (is)
CZ (1) CZ284256B6 (is)
DE (1) DE69117768T2 (is)
DK (1) DK0550612T3 (is)
EE (1) EE02979B1 (is)
ES (1) ES2084831T3 (is)
FI (1) FI111714B (is)
GR (1) GR3020134T3 (is)
HK (1) HK52297A (is)
HU (1) HU214054B (is)
IE (1) IE74387B1 (is)
IS (1) IS1684B (is)
LT (1) LT3813B (is)
LV (1) LV10770B (is)
NO (1) NO301709B1 (is)
PL (1) PL166434B1 (is)
PT (1) PT99051B (is)
RU (1) RU2079486C1 (is)
SE (1) SE9003057D0 (is)
SG (1) SG43150A1 (is)
SK (1) SK22793A3 (is)
WO (1) WO1992005147A1 (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US6299863B1 (en) 1992-04-03 2001-10-09 Sepracor Inc. Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
US6866839B2 (en) 1991-04-05 2005-03-15 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5629200A (en) * 1993-11-18 1997-05-13 Daicel Chemical Industries, Ltd. Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
WO1998021175A1 (en) * 1996-11-11 1998-05-22 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
US6040344A (en) 1996-11-11 2000-03-21 Sepracor Inc. Formoterol process
US6303145B2 (en) 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
AU2002252950A1 (en) * 2001-02-22 2002-09-04 Universitatsklinikum Charite Medizinische Fakultat Der Humboldt-Universitat Zu Berlin Protein kinase d inhibitors and protein kinase 2 inhibitors as agents for inhibiting tumour cells and for stimulating angiogenesis
US6472563B1 (en) 2001-11-09 2002-10-29 Sepracor Inc. Formoterol tartrate process and polymorph
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008035380A2 (en) * 2006-09-19 2008-03-27 Natco Pharma Limited An improved process for the preparation of high purity formoterol and its pharmaceutically acceptable salts
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
AU2008320590A1 (en) * 2007-10-29 2009-05-07 Generics [Uk] Limited Novel chromatography methods
JP4837800B2 (ja) 2008-05-13 2011-12-14 アストラゼネカ・アクチエボラーグ ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
CN101921200B (zh) * 2009-06-16 2014-01-15 上海医药工业研究院 一种n-苄基-1-(4-甲氧基苯基)-2-丙胺的制备方法
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
CN115368250B (zh) * 2022-09-02 2024-07-26 博诺康源(北京)药业科技有限公司 拆分福莫特罗手性中间体的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2366625C2 (is) * 1972-02-05 1988-06-09 Yamanouchi Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
GB1468156A (en) * 1973-07-19 1977-03-23 Ici Ltd Phenylethylamine derivatives
JPS643121A (en) 1987-06-25 1989-01-06 Mitsubishi Kasei Corp Remedy for endometriosis
ES2005492A6 (es) 1987-12-23 1989-03-01 Lasa Lab Procedimiento de obtencion de n-(2-hidroxi-5-(1-hidroxi-2((2- (4-metoxifenil)-1metiletil)amino)etil)fenil)foramida (i).

Also Published As

Publication number Publication date
NO931058D0 (no) 1993-03-23
ATE134990T1 (de) 1996-03-15
PL166434B1 (pl) 1995-05-31
AU8652091A (en) 1992-04-15
SG43150A1 (en) 1997-10-17
CZ44293A3 (en) 1994-01-19
JPH06501262A (ja) 1994-02-10
SK22793A3 (en) 1993-07-07
HU214054B (en) 1997-12-29
GR3020134T3 (en) 1996-08-31
DE69117768D1 (de) 1996-04-11
BG61605B1 (bg) 1998-01-30
LT3813B (en) 1996-03-25
AU652386B2 (en) 1994-08-25
NO301709B1 (no) 1997-12-01
HUT65912A (en) 1994-07-28
HK52297A (en) 1997-05-02
CZ284256B6 (cs) 1998-10-14
HU9300867D0 (en) 1993-06-28
JP2801401B2 (ja) 1998-09-21
WO1992005147A1 (en) 1992-04-02
FI111714B (fi) 2003-09-15
DK0550612T3 (da) 1996-07-22
CA2091343A1 (en) 1992-03-27
BG97576A (bg) 1994-03-31
ES2084831T3 (es) 1996-05-16
IS3756A7 (is) 1992-03-27
EP0550612B1 (en) 1996-03-06
LV10770B (en) 1996-04-20
IE74387B1 (en) 1997-07-30
FI931333A (fi) 1993-04-22
IE913373A1 (en) 1992-04-08
LV10770A (lv) 1995-08-20
PT99051A (pt) 1992-08-31
KR0179639B1 (ko) 1999-05-15
CA2091343C (en) 2002-07-09
LTIP1715A (en) 1995-07-25
RU2079486C1 (ru) 1997-05-20
IS1684B (is) 1998-02-24
PT99051B (pt) 1999-02-26
EP0550612A1 (en) 1993-07-14
NO931058L (no) 1993-03-23
DE69117768T2 (de) 1996-08-29
FI931333A0 (fi) 1993-03-25
SE9003057D0 (sv) 1990-09-26

Similar Documents

Publication Publication Date Title
EE02979B1 (et) Formoterool ja tema ühendid ning nende valmistamise meetod
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
FI102756B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi
RU93005269A (ru) Способ получения формотерола и родственных соединений
FI98455B (fi) Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
ZA918636B (en) Process for the preparation of piperazine derivatives
ES2071303T3 (es) Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.
NO972845L (no) FremgangsmÕte for fremstilling av et polyoksyalkylenderivat substituert med suksinimidylgruppe
ES488708A0 (es) Un procedimiento para preparar derivados de fenilpiperidina
FI911420A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
IT9019914A0 (it) Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
FI925518A (fi) Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi
FI910448A (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
NO179909C (no) Analogifremgangsmåte for fremstilling av terapeutisk avtive 6-substituerte purinylpiperazinderivater
DK0796256T3 (da) Fremgangsmåde til fremstilling af ranitidin
GB2066256A (en) Intermediate compounds for preparation of morphine derivatives
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
SE8900685D0 (sv) New compounds
FI940338A0 (fi) Menetelmä 13alfa-sinnamoyylibakkatiini III:n tai -10-desasetyylibakkatiini III:n valmistamiseksi
JO1652B1 (en) New compounds for local anesthesia and a way to prepare them
FI902356A0 (fi) Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
RU92016353A (ru) Производные катехола, способ их получения, применение и фармацевтическая композиция
FI922519A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi
FI922518A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi
NO950203D0 (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser